BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

The Medicines Company 

8 Sylvan Way

Parsippany  New Jersey  07054  U.S.A.
Phone: 973-290-6000 Fax: 973-656-9898


SEARCH JOBS

View Clinical Trials from BioPharm Insight




The Medicines Company's purpose is to save lives, alleviate suffering and contribute to the economics of healthcare by focusing on 3,000 leading acute/intensive care hospitals worldwide. Its vision is to be a leading provider of solutions in three areas: acute cardiovascular care, surgery and perioperative care, and serious infectious disease care. The company operates in the Americas, Europe and the Middle East, and Asia Pacific regions with global centers today in Parsippany, NJ, USA and Zurich, Switzerland.



 Key Statistics


Email: contactus@themedco.com
Ownership: Public

Web Site: The Medicines Company
Employees: 500+
Symbol: MDCO
 





Collaborations

UCB, Inc.  Contract manufacturing of Bivalirudin peptide active ingredient

Alnylam 





 Company News
The Medicines Company (MDCO) To Participate In Cowen and Company 35th Annual Health Care Conference 3/2/2015 10:25:58 AM
The Medicines Company (MDCO) To Participate In 2015 RBC Capital Markets' Global Healthcare Conference 2/23/2015 10:50:24 AM
The Medicines Company (MDCO) Will See Dynamic 2015, As Trials, Approvals Gain: Citi 2/20/2015 4:08:17 PM
The Medicines Company (MDCO) Reports Fourth Quarter And Full Year 2014 Financial Results 2/18/2015 1:51:56 PM
The Medicines Company (MDCO) To Participate In Leerink Global Healthcare Conference 2/5/2015 11:37:21 AM
The Medicines Company (MDCO) Acquires Annovation Biopharma, Inc. 2/4/2015 8:16:30 AM
The Medicines Company (MDCO) Receives CHMP Positive Opinions For Three Hospital Acute Care Products: KENGREXAL™ (cangrelor), ORBACTIV™ (oritavancin) And RAPLIXA™ (sealant powder) 1/23/2015 9:10:02 AM
The Medicines Company (MDCO) Prices $350 Million Of Convertible Notes 1/8/2015 1:56:25 PM
The Medicines Company (MDCO) Announces Intention To Offer $300 Million Of Convertible Notes 1/7/2015 10:50:18 AM
The Medicines Company (MDCO) To Participate In 33rd Annual J.P. Morgan Healthcare Conference 1/6/2015 11:22:33 AM
12345678910...